Close
Help




JOURNAL

Biomarkers in Cancer

53,768 Journal Article Views | Journal Analytics

An Antibody-based Blood Test Utilizing a Panel of Biomarkers as a New Method for Improved Breast Cancer Diagnosis

Submit a Paper



Publication Date: 19 Nov 2013

Type: Original Research

Journal: Biomarkers in Cancer

Citation: Biomarkers in Cancer 2013:5 71-80

doi: 10.4137/BIC.S13236

Abstract

In order to develop a new tool for diagnosis of breast cancer based on autoantibodies against a panel of biomarkers, a clinical trial including blood samples from 507 subjects was conducted. All subjects showed a breast abnormality on exam or breast imaging and final biopsy pathology of either breast cancer patients or healthy controls. Using an enzyme-linked immunosorbent assay, the samples were tested for autoantibodies against a predetermined number of biomarkers in various models that were used to determine a diagnosis, which was compared to the clinical status. Our new assay achieved a sensitivity of 95.2% [CI = 92.8–96.8%] at a fixed specificity of 49.5%. Receiver-operator characteristic curve analysis showed an area under the curve of 80.1% [CI = 72.6–87.6%]. These results suggest that a blood test which is based on models comprising several autoantibodies to specific biomarkers may be a new and novel tool for improving the diagnostic evaluation of breast cancer.


Downloads

PDF  (1.82 MB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

Supplementary Files 1  (251.19 KB ZIP FORMAT)

BibTex citation   (BIBDESK, LATEX)

XML






What Your Colleagues Say About Biomarkers in Cancer
The editorial staff of Biomarkers in Cancer are very efficient and helpful.  I am happy to work with them.  I look forward to reviewing future manuscripts.
Dr Xi Liu (National Cancer Institute, National Institutes of Health, Bethesda, MD, USA )
More Testimonials

Quick Links


New article and journal news notification services